C4 Therapeutics, Inc. (CCCC)
3.50
-0.01
(-0.28%)
USD |
NASDAQ |
Sep 14, 11:10
C4 Therapeutics Price to Book Value : 1.740 for Sept. 14, 2026
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| September 11, 2026 | 1.745 |
| September 10, 2026 | 1.69 |
| September 09, 2026 | 1.710 |
| September 08, 2026 | 1.765 |
| September 04, 2026 | 1.869 |
| September 03, 2026 | 1.859 |
| September 02, 2026 | 1.884 |
| September 01, 2026 | 1.924 |
| August 31, 2026 | 1.844 |
| August 28, 2026 | 1.914 |
| August 27, 2026 | 2.038 |
| August 26, 2026 | 2.108 |
| August 25, 2026 | 2.088 |
| August 24, 2026 | 2.038 |
| August 21, 2026 | 1.988 |
| August 20, 2026 | 2.003 |
| August 19, 2026 | 2.093 |
| August 18, 2026 | 2.078 |
| August 17, 2026 | 2.12 |
| August 14, 2026 | 2.108 |
| August 13, 2026 | 2.028 |
| August 12, 2026 | 1.938 |
| August 11, 2026 | 1.924 |
| August 10, 2026 | 1.799 |
| August 07, 2026 | 1.854 |
| Date | Value |
|---|---|
| August 06, 2026 | 1.809 |
| August 05, 2026 | 1.799 |
| August 04, 2026 | 1.794 |
| August 03, 2026 | 1.740 |
| July 31, 2026 | 1.730 |
| July 30, 2026 | 1.819 |
| July 29, 2026 | 1.750 |
| July 28, 2026 | 1.765 |
| July 27, 2026 | 1.784 |
| July 24, 2026 | 1.69 |
| July 23, 2026 | 1.814 |
| July 22, 2026 | 1.859 |
| July 21, 2026 | 1.904 |
| July 20, 2026 | 1.780 |
| July 17, 2026 | 1.834 |
| July 16, 2026 | 1.780 |
| July 15, 2026 | 1.889 |
| July 14, 2026 | 1.894 |
| July 13, 2026 | 1.948 |
| July 10, 2026 | 2.018 |
| July 09, 2026 | 2.132 |
| July 08, 2026 | 2.083 |
| July 07, 2026 | 2.162 |
| July 06, 2026 | 2.058 |
| July 02, 2026 | 2.137 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Beam Therapeutics, Inc. | 2.366 |
| Rallybio Corp. | 0.9379 |
| Q32 Bio, Inc. | 2.481 |
| Arrowhead Pharmaceuticals, Inc. | 24.68 |
| Oncolytics Biotech, Inc. | -- |
Price to Book Value Related Metrics
| PS Ratio | 11.14 |
| Price | 3.50 |
| Earnings Yield | -28.54% |
| Market Cap | 430.17M |